To help increase patient safety and prevent abuse and fraudulent activity, UnitedHealthcare Community Plan implemented new Concurrent Drug Utilization Review (cDUR) safety edits for pharmacy systems in October 2022.
These safety edits alert health care professionals to review the members’ current medications for therapeutic duplication, which may help prevent members from taking more than 1 drug in the same drug class.
We added the following drug classes and cDUR edits for our Community Plan:
|cDUR edit||Drug class||Affected states|
|Therapeutic duplication||Diabetes agents||AZ, CO, HI, IN, MD, MI, MN, NE, NJ, NV, NY, NY EPP, PA CHIP, RI, TX|
|Therapeutic duplication||Basal insulins||AZ, CO, HI, IN, MD, MI, MN, MS, NE, NJ, NV, NY, NY EPP, PA CHIP, RI, TX|
|Therapeutic duplication||Respiratory agents||AZ, CO, HI, IN, MD, MI, MN, MS, NE, NJ, NV, NY, NY EPP, PA CHIP, RI, TX|